Home › NDC Lookup › RxCUI directory › RxCUI 2475854

Vericiguat 2.5 MG Oral Tablet — RxCUI 2475854

Name: Vericiguat 2.5 MG Oral Tablet (RxCUI 2475854)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2475854 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2475854

Official nameVericiguat 2.5 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped3

Package NDCs mapped11

Reported Medicaid activity (SDUD)6,901 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vericiguat: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Verquvo is designed to lower your chances of dying from a heart-related cause or ending up back in the hospital because of your heart failure. It doesn't cure heart failure, but in...
What exactly is Verquvo supposed to do for me?
Yes — this one actually matters. Taking Verquvo with food significantly increases how much of the drug your body absorbs and makes your blood levels more predictable from day to da...
The two most common ones are low blood pressure and anemia (a drop in red blood cells). Low blood pressure can make you feel dizzy, lightheaded, or like you might faint — especiall...

📖 Read our full Vericiguat guide →

🕸️ Concept Web — How Vericiguat 2.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Vericiguat 2.5 MG Oral Tablet RxCUI 2475854 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Vericiguat 2475830 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Verquvo 2475847 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Vericiguat Oral Tablet 2475845 SCDF
- Vericiguat Oral Product 2475843 SCDG
- Vericiguat Pill 2475844 SCDG
- Vericiguat Oral Tablet [Verquvo] 2475849 SBDF
- Verquvo Oral Product 2475850 SBDG
- Verquvo Pill 2475851 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Vericiguat 2.5 MG 2475853 SCDC
- Vericiguat 2.5 MG Oral Tablet [Verquvo] 2475856 SBD
- Vericiguat 2.5 MG [Verquvo] 2475855 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Vericiguat 2.5 MG SCDC · 2475853
Vericiguat Oral Tablet SCDF · 2475845
Vericiguat Oral Product SCDG · 2475843
Vericiguat Pill SCDG · 2475844

Brand-Name Concepts

Vericiguat 2.5 MG Oral Tablet [Verquvo] SBD · 2475856
Vericiguat 2.5 MG [Verquvo] SBDC · 2475855
Vericiguat Oral Tablet [Verquvo] SBDF · 2475849
Verquvo Oral Product SBDG · 2475850
Verquvo Pill SBDG · 2475851
Verquvo BN · 2475847

📦 FDA Products & Package NDCs

3 products · 11 package NDCs

11 package NDCs map to RxCUI 2475854 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00006-5028-01	14 TABLET, FILM COATED in 1 BOTTLE (0006-5028-01)	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5028-02	30 TABLET, FILM COATED in 1 BOTTLE (0006-5028-02)	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5028-04	10 BLISTER PACK in 1 CARTON (0006-5028-04) / 10 TABLET, FIL...	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5028-06	1 BOTTLE in 1 CARTON (0006-5028-06) / 14 TABLET, FILM COATE...	VERQUVO	Merck Sharp & Dohme LLC	2023-04-01
00006-5029-01	14 TABLET, FILM COATED in 1 BOTTLE (0006-5029-01)	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5029-02	30 TABLET, FILM COATED in 1 BOTTLE (0006-5029-02)	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5029-04	10 BLISTER PACK in 1 CARTON (0006-5029-04) / 10 TABLET, FIL...	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5029-06	1 BOTTLE in 1 CARTON (0006-5029-06) / 14 TABLET, FILM COATE...	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5030-01	30 TABLET, FILM COATED in 1 BOTTLE (0006-5030-01)	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5030-02	90 TABLET, FILM COATED in 1 BOTTLE (0006-5030-02)	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01
00006-5030-04	10 BLISTER PACK in 1 CARTON (0006-5030-04) / 10 TABLET, FIL...	VERQUVO	Merck Sharp & Dohme LLC	2021-02-01

Observed labelers: Merck Sharp & Dohme LLC (11) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.